SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-027982
Filing Date
2024-03-07
Accepted
2024-03-07 16:19:08
Documents
75
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K virx-20231231.htm   iXBRL 10-K 2602135
2 EX-10.30 virx-ex10_30.htm EX-10.30 384158
3 EX-10.31 virx-ex10_31.htm EX-10.31 33398
4 EX-10.32 virx-ex10_32.htm EX-10.32 28397
5 EX-10.33 virx-ex10_33.htm EX-10.33 76790
6 EX-23.1 virx-ex23_1.htm EX-23.1 10062
7 EX-31.1 virx-ex31_1.htm EX-31.1 15491
8 EX-31.2 virx-ex31_2.htm EX-31.2 15194
9 EX-32.1 virx-ex32_1.htm EX-32.1 12388
10 EX-97.1 virx-ex97_1.htm EX-97.1 46887
11 GRAPHIC img99343570_0.jpg GRAPHIC 30718
12 GRAPHIC img99343570_1.jpg GRAPHIC 26096
13 GRAPHIC img99343570_2.jpg GRAPHIC 18340
14 GRAPHIC img99343570_3.jpg GRAPHIC 32692
15 GRAPHIC img99343570_4.jpg GRAPHIC 35635
16 GRAPHIC img99343570_5.jpg GRAPHIC 20804
  Complete submission text file 0000950170-24-027982.txt   11235847

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT virx-20231231.xsd EX-101.SCH 1435330
77 EXTRACTED XBRL INSTANCE DOCUMENT virx-20231231_htm.xml XML 1858572
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 24730401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)